DoximityDOCS
DOCS
About: Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
Employees: 830
0
Funds holding %
of 7,296 funds
0
Analysts bullish %
of 11 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
127% more first-time investments, than exits
New positions opened: 111 | Existing positions closed: 49
48% more repeat investments, than reductions
Existing positions increased: 196 | Existing positions reduced: 132
25% more funds holding in top 10
Funds holding in top 10: 4 [Q4 2024] → 5 (+1) [Q1 2025]
18% more capital invested
Capital invested by funds: $6.18B [Q4 2024] → $7.27B (+$1.1B) [Q1 2025]
13% more funds holding
Funds holding: 427 [Q4 2024] → 481 (+54) [Q1 2025]
3.57% more ownership
Funds ownership: 90.32% [Q4 2024] → 93.89% (+3.57%) [Q1 2025]
7% less call options, than puts
Call options by funds: $101M | Put options by funds: $109M
Research analyst outlook
11 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$50
11%
downside
Avg. target
$62
10%
upside
High target
$80
43%
upside
11 analyst ratings
5 positive
45%
6 neutral
55%
0 negative
0%
BTIG David Larsen | 43%upside $80 | Buy Upgraded | 2 Jun 2025 |
JP Morgan Anne Samuel | 7%upside $60 | Neutral Maintained | 27 May 2025 |
Goldman Sachs David Roman | 11%downside $50 | Neutral Maintained | 21 May 2025 |
Baird Vikram Kesavabhotla | 16%upside $65 | Outperform Maintained | 20 May 2025 |
Mizuho Steven Valiquette | 7%upside $60 | Neutral Maintained | 16 May 2025 |
Financial journalist opinion
Based on 20 articles about DOCS published over the past 30 days
Neutral
GlobeNewsWire
2 days ago
Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm
NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders.
Positive
Zacks Investment Research
3 days ago
DOCS Boosts Client Retention via Workflow Integration and AI Tools
Doximity strengthens client loyalty by embedding AI tools and clinical workflows into its platform for medical professionals.
Neutral
PRNewsWire
5 days ago
Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm
NEW YORK , June 9, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Doximity caused the company to misrepresent or fail to disclose material information concerning the Company's business and operations.
Neutral
GlobeNewsWire
1 week ago
Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders.
Positive
Zacks Investment Research
1 week ago
Doximity Declines 4.4% in a Month: How to Play the Stock Now?
Over the past month, Doximity's DOCS shares have lost approximately 4.4% despite the company reporting solid fourth-quarter fiscal 2025 results with $138.3 million in revenues and a 50% adjusted EBITDA margin. For fiscal 2025, revenues totaled $570.4 million, up 20% year over year, with adjusted EBITDA rising 36% to $313.8 million and margin expanding to 55%.
Positive
24/7 Wall Street
1 week ago
The “English Warren Buffett” Dumped Most of His Portfolio, But Bought Big Into These 3 Stocks
His concentrated portfolio strategy, focusing on high-quality, long-term holdings, reflects a disciplined, tech-heavy investment approach.
Positive
Zacks Investment Research
1 week ago
Doximity Rides on Telehealth Demand: Will This Drive Sales Further?
DOCS posts strong Q4 revenue growth and record user engagement as demand for telehealth and AI tools hits new highs.
Positive
Schaeffers Research
1 week ago
Which Telehealth Stock Should You Be Targeting?
Hims & Hers Health Inc (NYSE:HIMS) stock made waves in premarket trading, after the telehealth firebrand announced the pending acquisition of ZAVA, a European digital health platform.
Neutral
GlobeNewsWire
3 weeks ago
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors.
Neutral
Business Wire
3 weeks ago
Doximity to Present at the William Blair 45th Annual Growth Stock Conference
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025 at 4:40 p.m. Central Time. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties a.
Charts implemented using Lightweight Charts™